# VANFLYTA

NDC: 65597-511
Generic name: QUIZARTINIB
Labeler / Manufacturer: Daiichi Sankyo Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20230720

FDA application: NDA216993

## Active ingredients

- QUIZARTINIB DIHYDROCHLORIDE: 26.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65597-511"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65597-511
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29cdbcfe-497d-4e78-bb7b-2d4acafe8e86